• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

利用疫苗减少抗生素使用并预防抗生素耐药性：世界卫生组织行动框架。

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.

机构信息

Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), Geneva, Switzerland.

Division of Gastrointestinal Sciences, Christian Medical College, Vellore TN, India.

出版信息

Clin Infect Dis. 2021 Aug 16;73(4):e1011-e1017. doi: 10.1093/cid/ciab062.

DOI:10.1093/cid/ciab062
PMID:33493317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8366823/
Abstract

This Action Framework identifies priority actions to prevent antimicrobial-resistant (AMR) through expanding the use of licensed vaccines, developing new vaccines that contribute to the prevention and control of AMR, and expanding knowledge about the impact of vaccines on AMR.

摘要

本行动框架确定了通过扩大许可疫苗的使用、开发有助于预防和控制抗菌素耐药性的新疫苗以及扩大疫苗对抗菌素耐药性影响的知识等措施来预防抗菌素耐药性（AMR）的优先行动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be17/8366823/410df5fb694c/ciab062f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be17/8366823/410df5fb694c/ciab062f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be17/8366823/410df5fb694c/ciab062f0001.jpg

相似文献

1
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.利用疫苗减少抗生素使用并预防抗生素耐药性：世界卫生组织行动框架。
Clin Infect Dis. 2021 Aug 16;73(4):e1011-e1017. doi: 10.1093/cid/ciab062.
2
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance.世界卫生组织明确疫苗在对抗抗微生物药物耐药性方面的作用并确保其产生影响的方法。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2145069. doi: 10.1080/21645515.2022.2145069. Epub 2022 Nov 24.
3
World Antibiotic Awareness Week.世界提高抗生素认识周。
Ann Acad Med Singap. 2017 Nov;46(11):413-414.
4
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.巴基斯坦抗菌药物耐药性国家行动计划进展：叙述性综述及影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93. doi: 10.1080/14787210.2021.1935238. Epub 2021 Jul 26.
5
The role of vaccines in preventing bacterial antimicrobial resistance.疫苗在预防细菌对抗菌药物耐药性中的作用。
Nat Med. 2018 Jan 9;24(1):10-19. doi: 10.1038/nm.4465.
6
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.重症监护病房中的抗菌药物耐药性和抗生素管理计划：在抗耐药斗争中的坚持和持续努力。ESICM/ESCMID/WAAAR 多药耐药圆桌会议立场声明。
Intensive Care Med. 2018 Feb;44(2):189-196. doi: 10.1007/s00134-017-5036-1. Epub 2017 Dec 29.
7
Transdisciplinary work against antimicrobial resistance.跨学科抗击抗菌药物耐药性工作。
Lancet Infect Dis. 2020 May;20(5):526-527. doi: 10.1016/S1473-3099(20)30137-7. Epub 2020 Mar 5.
8
Proxy indicators for antibiotic consumption; surveillance needed to control antimicrobial resistance.抗生素消费的替代指标；控制抗菌药物耐药性所需的监测
Bull World Health Organ. 2019 Jan 1;97(1):3-3A. doi: 10.2471/BLT.18.227348.
9
Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship.通过提高门诊环境中的健康素养降低抗菌药物耐药性危害：推进抗菌药物管理的一种被低估的方法。
Adv Ther. 2020 Feb;37(2):918-932. doi: 10.1007/s12325-019-01203-1. Epub 2020 Jan 17.
10
BSAC Vanguard Series: The future of antibiotic stewardship-managing access and excess.BSAC 先锋系列：抗生素管理的未来——管理途径和过剩。
J Antimicrob Chemother. 2022 Mar 31;77(4):863-864. doi: 10.1093/jac/dkab423.

引用本文的文献

1
COVID-19 vaccination and use of antibiotics in COVID-19 patients: a systematic review and meta-analysis.2019冠状病毒病患者的2019冠状病毒病疫苗接种及抗生素使用：一项系统评价与荟萃分析
Infect Prev Pract. 2025 Jun 3;7(3):100461. doi: 10.1016/j.infpip.2025.100461. eCollection 2025 Sep.
2
Alternative therapeutic approaches for combating multi-drug-resistant bacteria: Reverse vaccinology against Enterobacter cloacae.对抗多重耐药菌的替代治疗方法：针对阴沟肠杆菌的反向疫苗学
J Genet Eng Biotechnol. 2025 Sep;23(3):100519. doi: 10.1016/j.jgeb.2025.100519. Epub 2025 Jun 17.
3
County Influenza Vaccination Rates and Antibiotic Prescribing Rates in US Nursing Homes.

本文引用的文献

1
Immunization agenda 2030: A global strategy to leave no one behind.《2030年免疫议程：不让任何人掉队的全球战略》
Vaccine. 2024 Apr 8;42 Suppl 1:S5-S14. doi: 10.1016/j.vaccine.2022.11.042.
2
Childhood vaccines and antibiotic use in low- and middle-income countries.儿童疫苗接种和中低收入国家的抗生素使用。
Nature. 2020 May;581(7806):94-99. doi: 10.1038/s41586-020-2238-4. Epub 2020 Apr 29.
3
Antibiotic development - economic, regulatory and societal challenges.抗生素研发——经济、监管及社会挑战
美国疗养院的县流感疫苗接种率和抗生素处方率
Public Health Rep. 2025 Jul 5:333549251342746. doi: 10.1177/00333549251342746.
4
The neglected model validation of antimicrobial resistance transmission models - a systematic review.抗菌药物耐药性传播模型中被忽视的模型验证——一项系统综述
Antimicrob Resist Infect Control. 2025 May 28;14(1):59. doi: 10.1186/s13756-025-01574-x.
5
Group B Streptococcus maternal colonization and neonatal sepsis in Belgium between 2012 and 2021: a description of the epidemiological situation and identification of risk factors.2012年至2021年比利时B族链球菌母婴定植与新生儿败血症：流行病学情况描述及危险因素识别
BMC Pregnancy Childbirth. 2025 May 22;25(1):599. doi: 10.1186/s12884-025-07695-w.
6
Mapping the role of vaccines in combating AMR in the WHO African region: a scoping review and implications for research and policy.梳理疫苗在世界卫生组织非洲区域抗击抗菌药物耐药性中的作用：一项范围综述及对研究和政策的启示
BMC Infect Dis. 2025 May 15;25(1):702. doi: 10.1186/s12879-025-11080-5.
7
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.咨询报告——关于用于流行国家的二价伤寒沙门氏菌/甲型副伤寒沙门氏菌疫苗监管途径的考量
Vaccine. 2025 May 22;56:127189. doi: 10.1016/j.vaccine.2025.127189. Epub 2025 May 1.
8
Vaccination, Public Health and Health Communication: A Network of Connections to Tackle Global Challenges.疫苗接种、公共卫生与健康传播：应对全球挑战的联系网络
Vaccines (Basel). 2025 Feb 27;13(3):245. doi: 10.3390/vaccines13030245.
9
Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.迈向肺部感染的整体治疗方法。来自2024年西班牙专家第六届年会的见解。
Rev Esp Quimioter. 2025 Mar 27;38(3):152-186. doi: 10.37201/req/017.2025.
10
Identification of cross-reactive vaccine antigen candidates in Gram-positive ESKAPE pathogens through subtractive proteome analysis using opsonic sera.通过使用调理血清的消减蛋白质组分析鉴定革兰氏阳性ESKAPE病原体中的交叉反应性疫苗抗原候选物。
PLoS One. 2025 Mar 26;20(3):e0319933. doi: 10.1371/journal.pone.0319933. eCollection 2025.
Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.
4
Impact of vaccination on antibiotic usage: a systematic review and meta-analysis.疫苗接种对抗生素使用的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Oct;25(10):1213-1225. doi: 10.1016/j.cmi.2019.06.030. Epub 2019 Jul 5.
5
Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.预测伤寒结合疫苗对耐药性的影响。
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S96-S104. doi: 10.1093/cid/ciy1108.
6
Antimicrobial resistance and the role of vaccines.抗菌药物耐药性与疫苗的作用。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12868-12871. doi: 10.1073/pnas.1717157115.
7
Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.现有疫苗在减少抗生素耐药性方面的影响：主要和次要效应。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12896-12901. doi: 10.1073/pnas.1721095115.
8
Microbiome as a tool and a target in the effort to address antimicrobial resistance.微生物组作为解决抗微生物药物耐药性问题的工具和目标。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12902-12910. doi: 10.1073/pnas.1717163115.
9
Introduction and geographic availability of new antibiotics approved between 1999 and 2014.1999 年至 2014 年间批准的新型抗生素的介绍和地理可获得性。
PLoS One. 2018 Oct 16;13(10):e0205166. doi: 10.1371/journal.pone.0205166. eCollection 2018.
10
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.发现、研究和开发新抗生素：世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.